2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Prostatic Neoplasms
25
Neoplasms
13
Carcinoma, Non-Small-Cell Lung
13
Breast Neoplasms
13
Colonic Neoplasms
9
Uterine Cervical Neoplasms
7
Lung Neoplasms
6
Colorectal Neoplasms
6
Urinary Bladder Neoplasms
5
Melanoma
5
Leukemia, Myeloid, Acute
5
Carcinoma, Renal Cell
5
Uterine Cervical Dysplasia
4
Lymphoma, Large B-Cell, Diffuse
4
Esophageal Neoplasms
4
Brain Neoplasms
4
Thrombocythemia, Essential
3
Rectal Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Polycythemia Vera
3
Papillomavirus Infections
3
Oropharyngeal Neoplasms
3
Neuroblastoma
3
Mouth Neoplasms
3
Liver Neoplasms
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Hodgkin Disease
3
Glioma
3
Gallbladder Neoplasms
3
Carcinoma, Hepatocellular
3
Interventions
Carboplatin
5
Paclitaxel
4
pembrolizumab
3
Educational Status
3
niraparib
2
anlotinib
2
Therapeutic Touch
2
Surveys and Questionnaires
2
Standard of Care
2
Radiotherapy
2
Pemetrexed
2
Palliative Care
2
Nivolumab
2
Methods
2
Interviews as Topic
2
Gemcitabine
2
Early Intervention, Educational
2
Bevacizumab
2
temsirolimus
1
rucaparib
1
relacorilant
1
olaparib
1
nintedanib
1
nilotinib
1
liposomal doxorubicin
1
lenvatinib
1
fosaprepitant
1
atezolizumab
1
argatroban
1
Watchful Waiting
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Genital Neoplasms, Female
×
Watchful Waiting
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled